Tobacco Smoking Reduces the Odds of Psoriasis Improvement
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 24, 2024 -- Tobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.
Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The analysis included 560 patients with psoriasis (72.9 percent were men).
The researchers found that a higher proportion of patients without tobacco smoking achieved ≥75 percent reduction in the Psoriasis Area and Severity Index (PASI75) score at week 8. For nonsmokers versus smokers, current smokers, and former smokers, the odds of PASI75 were greater (adjusted odds ratios, 11.43, 14.14, and 3.05, respectively). Compared with current smokers, former smokers had higher PASI75 achievement (adjusted odds ratio, 3.37). Individuals with younger smoking initiation age, longer smoking duration, and higher smoking intensity had lower PASI75 achievement.
"Tobacco smoking was negatively associated with the proportion of PASI75 achievement among patients with psoriasis, both for those with current or former tobacco smoking habits. Moreover, former smokers had a higher proportion of PASI75 achievement than current smokers," the authors write. "We recommend the implementation of tobacco control measures, the provision of patient-centered, culturally sensitive cessation guides, and bedside support to improve the treatment response among patients with psoriasis."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 -- Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to...
Cytisinicline Beneficial for Cessation of Electronic Cigarette Smoking
MONDAY, May 13, 2024 -- Cytisinicline for 12 weeks with behavioral support is efficacious for cessation of electronic cigarette smoking, according to a study published online May...
Upping Dose May Aid Smoking Cessation After Initial Treatment Failure
TUESDAY, May 7, 2024 -- A dosage increase may provide longer-term benefit for smokers receiving varenicline or combination nicotine replacement therapy who are nonabstinent after...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.